Glenmark takes aim at Celgene’s Abraxane with complex generic deal

Posted: September 22nd, 2016  |  Company/topic: Celgene
Glenmark takes aim at Celgene's Abraxane with complex generic deal phil Thu, 09/22/2016 - 11:31…

Could Biotech’s Bestie Celgene Be Getting Ready to Unveil Another Deal?

Posted: September 15th, 2016  |  Company/topic: Celgene
September 16, 2016By Alex Keown, BioSpace.com Breaking...

Celgene Announces Interim Topline Data from Trial of Investigational Oral GED0301 in Patients with Active Crohns Disease

Posted: September 14th, 2016  |  Company/topic: Celgene
Monday September 12th 2016 at 1130am UTC Data show endoscopic improvement and clinical response and remission at week 12 Safety and tolerability consistent with previous studies Results expected to be…

Riding higher on Celgene filing, Agios proposes $150M offering to fund late-phase trials

Posted: September 14th, 2016  |  Company/topic: Celgene
Riding higher on Celgene filing, Agios proposes $150M offering to fund late-phase trials ntaylor Wed, 09/14/2016 - 04:28…